Medications

OxyContin maker reaches tentative opioid-crisis settlement

OxyContin maker Purdue Pharma reached a tentative deal Wednesday with about half the states and thousands of local governments over its role in the nation's deadly opioid epidemic, but criticism by several state attorneys ...

Medications

Source: OxyContin maker seeks to resolve all lawsuits

A settlement being pursued by the maker of OxyContin aims to resolve all claims against the company filed in both state and federal courts and provides a formula for dividing a pot of money reaching into the billions, The ...

Medications

Report: J&J will pay $2.2B in Risperdal settlement

(AP) — Johnson & Johnson has agreed to pay as much as $2.2 billion to resolve an investigation into its marketing of the anti-psychotic drug Risperdal, according to a published report.

Medications

Purdue Pharma begins Chapter 11 bankruptcy journey

Purdue Pharma gets its day in court Tuesday after the OxyContin maker filed for bankruptcy and negotiated a potential multi-billion dollar settlement to resolve thousands of lawsuits.

Medical economics

Disability in a pandemic—Africa's forgotten families

In 2017, a road accident left Anna Nzioka with two fractures in her right leg. After a series of operations and physiotherapy, she has slowly learned to walk again, although with the aid of a crutch.

page 4 from 9